looking forward for their drugs to be in the market. it will be the only time BLRX price will move up.
Sppi is just moving sideways for the last 3 years even though it has acquired 5 drugs that are being marketed in the market. Does not look that it is going to break away soon. Raj should go and may be the stock will get
This stock should be above $20 if Raj and his highly paid lieutenants have been replaced. Revenues have been going up but never showed any profits.
I have been holding on this stock for 3 long years and every quarter I have been frustrated with the outcome of the financial statement reporting loses every quarter with many drugs in the market. There is lack of execution on the part of the top management to cut cost because
most of the expenses goes to their stock options, salaries and bonuses.
SPPI has a lot of drugs in the market, yet it keeps on losing money. Too much salary and stock options to Raj and his lieutenants that is why it keep on losing money. Nobody wants to touch SPPI till it shows it can generate profit. This company just keep on losing its value. Time for Raj to go.
Will CPRX reach $10 when it gets the FDA nod or will it get a buy out offer?
Sentiment: Strong Buy
SPPI is in the dog house of wall street. There is no volume or up tick on the trade no matter
what good news it brings out. Its just frustrating for people who have been holding on this stock for so long. There is just no love for this stock. Raj and his management team is just making too much for themselves in terms of salaries, bonuses and options. as if this company is a large cap company.
When is INO coming out with the VGX 3100 result. It was said that 3rd quarter was supposedly the
announcement of the result.
That's the truth even though I own shares, it really sucks. Lymphoseek is not being used
and the marketing deal that they have is not working. Since Lymphoseek is in the market,
the stock have dropped from $3.50 to $1.30 now. What a laugher.
CTIC is looking for licensing agreement, must be very positive on the phase III trials for its drugs.
Could easily get to $7-10 when the time they will announce the results of Phase III for Pixubri
Apple has a breaking demand for its iphone, if PXLW, technology is being used on the iphone camera,
why is the stock price keeps on going down? There was too much hype on the buy-out by Apple a month
ago and now that rumor has fizzled and PXLW is hung to dry. Is this still a growth company?
SPPI should/could be easily in the $25 to $30 range with its drugs in the market and some drugs in late clinical
trials. What's holding it back in my opinion is the management. They don't have the ability to control expenses.
Despite the drugs in the market, SPPI keeps on reporting loses every quarter.
What is the reason why doctors are not prescribing Belvique or other diet pills. There are so many obese people in the world and they are not using diet pills, what is wrong with these people?
SPPI did not release the results on SPI-2012, in my opinion is that no matter how successful the clinical results are on their drugs, the stock price hardly moves up while other bio-pharmaceuticals whenever
they announce a positive results on phase I or II, their stock price moves up as if there was an FDA approval.
SPPI is scorned by the wall street people and shorted by traders all the time.
Me as an investor of SPPI have been frustrated for so long and could put the blame on the management
for the underperformance of this company. They have so many drugs in the market yet it is always
reporting loses while other companies without any drugs in the market keep on flourishing with high stock prices.
I still think Raj is the main reason this company is not heading upward in price. He should give up his seat
along with his lieutenants. SPPI is still posting loses despite the 5 drugs in the market. They are putting too much money in their pocket.
Sell the company now before it loses all its cash that it raised when it sold shares before the FDA approval of Belviq.
$16 to $17 is a low estimate. They have too many drugs in the market + more in clinical trials.
There are many small pharma that are worth more without any drugs in the market. Raj is the only
sticking point why this company is not moving any higher. SPPI should be around $30 with
good execution in marketing SPPI's products.